Announcing our 2012 Childhood Cancer Research Grants
We are proud to announce the funding of five innovative research projects that we believe will make a real, lasting effect on childhood cancer treatment. Here are the projects our Board of Directors and esteemed Scientific Advisory Committee selected for funding:
Role of the GAB2-SHP2 network in childhood neuroblastoma pathogenesis
Shizen Zhu, MD, PhD
Dana Farber Cancer Institute
Phase I/II clinical trial evaluating NK cell immunotherapy in relapsed and refractory pediatric solid tumors
Monica Thakar, MD
Children’s Hospital of Wisconsin/Medical College of Wisconsin
Elucidating Epigenetic Mechanisms for Therapeutic Targeting in Aggressive Pediatric Cancers
Boris Wilson, PhD
Dana Farber Cancer Institute
Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer
Chungling Yi, PhD
Lombardi Cancer Center at Georgetown University
We are also proud to renew funding for the following project based upon excellent progress reports:
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients with Relapsed or Refractory Solid Tumors
Holly Meany, MD
Children’s National Medical Center
Learn more about out 2012 Childhood Cancer Research Grants at pablove.org/grants.